EPAC1 overexpression is a prognostic marker and its inhibition shows promising therapeutic potential for gastric cancer

Ding Ping Sun, Chia Lang Fang, Han Kun Chen, Kuo Shan Wen, You Cheng Hseu, Shih Ting Hung, Yih Huei Uen, Kai Yuan Lin

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

cAMP signaling controls a variety of cellular functions. In addition to the well-known signal transducer cAMP-dependent protein kinase, a more recently discovered transducer is the exchange protein directly activated by cAMP (EPAC). EPAC responses are mediated by small G proteins, which regulate biologic functions such as cell adhesion, migration and proliferation. Recently, the clinical importance of EPAC1 has received increased attention. This study investigated the correlations between the expression of EPAC1 and various clinicopathologic parameters as well as the survival of the patients with gastric cancer (GC). The patient cohort in this study consisted of 141 cases of GC that presented from 1999 through 2011; documented clinicopathologic parameters and clinical outcomes were available for all cases. Immunoblotting, immunohistochemistry and quantitative real-Time PCR were used to examine EPAC1 expression in gastric cells and tissues. siRNA technology was used to study the effect of EPAC1 knockdown on cell proliferation and invasion. An increase in EPAC1 expression was found in GC cells and tissues. The overexpression of EPAC1 was associated with the depth of invasion (P=0.0021), stage (P=0.0429), and vascular invasion (P=0.0049) and was correlated with poor disease-free survival (P=0.0029) and overall survival (P=0.0024). A univariate Cox regression analysis showed that the overexpression of EPAC1 was a prognostic marker for GC (P=0.038). Furthermore, cell studies indicated that the knockdown of EPAC1 in GC cells suppressed cell proliferation and invasion. The overexpression of EPAC1 can be used as a marker to predict the outcome of patients with GC, and EPAC1 represents a potential therapeutic modality for treating GC.

Original languageEnglish
Pages (from-to)1953-1960
Number of pages8
JournalOncology Reports
Volume37
Issue number4
DOIs
Publication statusPublished - Apr 1 2017

Fingerprint

Stomach Neoplasms
Cell Proliferation
Transducers
Therapeutics
Monomeric GTP-Binding Proteins
Survival
Cyclic AMP-Dependent Protein Kinases
Immunoblotting
Cell Adhesion
Small Interfering RNA
Disease-Free Survival
Cell Movement
Blood Vessels
Real-Time Polymerase Chain Reaction
Stomach
Proteins
Cohort Studies
Immunohistochemistry
Regression Analysis
Technology

Keywords

  • Exchange protein directly activated by cAMP
  • Gastric cancer
  • Prognosis

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

EPAC1 overexpression is a prognostic marker and its inhibition shows promising therapeutic potential for gastric cancer. / Sun, Ding Ping; Fang, Chia Lang; Chen, Han Kun; Wen, Kuo Shan; Hseu, You Cheng; Hung, Shih Ting; Uen, Yih Huei; Lin, Kai Yuan.

In: Oncology Reports, Vol. 37, No. 4, 01.04.2017, p. 1953-1960.

Research output: Contribution to journalArticle

Sun, Ding Ping ; Fang, Chia Lang ; Chen, Han Kun ; Wen, Kuo Shan ; Hseu, You Cheng ; Hung, Shih Ting ; Uen, Yih Huei ; Lin, Kai Yuan. / EPAC1 overexpression is a prognostic marker and its inhibition shows promising therapeutic potential for gastric cancer. In: Oncology Reports. 2017 ; Vol. 37, No. 4. pp. 1953-1960.
@article{10e635a158b3410e9b2f0910f2512def,
title = "EPAC1 overexpression is a prognostic marker and its inhibition shows promising therapeutic potential for gastric cancer",
abstract = "cAMP signaling controls a variety of cellular functions. In addition to the well-known signal transducer cAMP-dependent protein kinase, a more recently discovered transducer is the exchange protein directly activated by cAMP (EPAC). EPAC responses are mediated by small G proteins, which regulate biologic functions such as cell adhesion, migration and proliferation. Recently, the clinical importance of EPAC1 has received increased attention. This study investigated the correlations between the expression of EPAC1 and various clinicopathologic parameters as well as the survival of the patients with gastric cancer (GC). The patient cohort in this study consisted of 141 cases of GC that presented from 1999 through 2011; documented clinicopathologic parameters and clinical outcomes were available for all cases. Immunoblotting, immunohistochemistry and quantitative real-Time PCR were used to examine EPAC1 expression in gastric cells and tissues. siRNA technology was used to study the effect of EPAC1 knockdown on cell proliferation and invasion. An increase in EPAC1 expression was found in GC cells and tissues. The overexpression of EPAC1 was associated with the depth of invasion (P=0.0021), stage (P=0.0429), and vascular invasion (P=0.0049) and was correlated with poor disease-free survival (P=0.0029) and overall survival (P=0.0024). A univariate Cox regression analysis showed that the overexpression of EPAC1 was a prognostic marker for GC (P=0.038). Furthermore, cell studies indicated that the knockdown of EPAC1 in GC cells suppressed cell proliferation and invasion. The overexpression of EPAC1 can be used as a marker to predict the outcome of patients with GC, and EPAC1 represents a potential therapeutic modality for treating GC.",
keywords = "Exchange protein directly activated by cAMP, Gastric cancer, Prognosis",
author = "Sun, {Ding Ping} and Fang, {Chia Lang} and Chen, {Han Kun} and Wen, {Kuo Shan} and Hseu, {You Cheng} and Hung, {Shih Ting} and Uen, {Yih Huei} and Lin, {Kai Yuan}",
year = "2017",
month = "4",
day = "1",
doi = "10.3892/or.2017.5442",
language = "English",
volume = "37",
pages = "1953--1960",
journal = "Oncology Reports",
issn = "1021-335X",
publisher = "Spandidos Publications",
number = "4",

}

TY - JOUR

T1 - EPAC1 overexpression is a prognostic marker and its inhibition shows promising therapeutic potential for gastric cancer

AU - Sun, Ding Ping

AU - Fang, Chia Lang

AU - Chen, Han Kun

AU - Wen, Kuo Shan

AU - Hseu, You Cheng

AU - Hung, Shih Ting

AU - Uen, Yih Huei

AU - Lin, Kai Yuan

PY - 2017/4/1

Y1 - 2017/4/1

N2 - cAMP signaling controls a variety of cellular functions. In addition to the well-known signal transducer cAMP-dependent protein kinase, a more recently discovered transducer is the exchange protein directly activated by cAMP (EPAC). EPAC responses are mediated by small G proteins, which regulate biologic functions such as cell adhesion, migration and proliferation. Recently, the clinical importance of EPAC1 has received increased attention. This study investigated the correlations between the expression of EPAC1 and various clinicopathologic parameters as well as the survival of the patients with gastric cancer (GC). The patient cohort in this study consisted of 141 cases of GC that presented from 1999 through 2011; documented clinicopathologic parameters and clinical outcomes were available for all cases. Immunoblotting, immunohistochemistry and quantitative real-Time PCR were used to examine EPAC1 expression in gastric cells and tissues. siRNA technology was used to study the effect of EPAC1 knockdown on cell proliferation and invasion. An increase in EPAC1 expression was found in GC cells and tissues. The overexpression of EPAC1 was associated with the depth of invasion (P=0.0021), stage (P=0.0429), and vascular invasion (P=0.0049) and was correlated with poor disease-free survival (P=0.0029) and overall survival (P=0.0024). A univariate Cox regression analysis showed that the overexpression of EPAC1 was a prognostic marker for GC (P=0.038). Furthermore, cell studies indicated that the knockdown of EPAC1 in GC cells suppressed cell proliferation and invasion. The overexpression of EPAC1 can be used as a marker to predict the outcome of patients with GC, and EPAC1 represents a potential therapeutic modality for treating GC.

AB - cAMP signaling controls a variety of cellular functions. In addition to the well-known signal transducer cAMP-dependent protein kinase, a more recently discovered transducer is the exchange protein directly activated by cAMP (EPAC). EPAC responses are mediated by small G proteins, which regulate biologic functions such as cell adhesion, migration and proliferation. Recently, the clinical importance of EPAC1 has received increased attention. This study investigated the correlations between the expression of EPAC1 and various clinicopathologic parameters as well as the survival of the patients with gastric cancer (GC). The patient cohort in this study consisted of 141 cases of GC that presented from 1999 through 2011; documented clinicopathologic parameters and clinical outcomes were available for all cases. Immunoblotting, immunohistochemistry and quantitative real-Time PCR were used to examine EPAC1 expression in gastric cells and tissues. siRNA technology was used to study the effect of EPAC1 knockdown on cell proliferation and invasion. An increase in EPAC1 expression was found in GC cells and tissues. The overexpression of EPAC1 was associated with the depth of invasion (P=0.0021), stage (P=0.0429), and vascular invasion (P=0.0049) and was correlated with poor disease-free survival (P=0.0029) and overall survival (P=0.0024). A univariate Cox regression analysis showed that the overexpression of EPAC1 was a prognostic marker for GC (P=0.038). Furthermore, cell studies indicated that the knockdown of EPAC1 in GC cells suppressed cell proliferation and invasion. The overexpression of EPAC1 can be used as a marker to predict the outcome of patients with GC, and EPAC1 represents a potential therapeutic modality for treating GC.

KW - Exchange protein directly activated by cAMP

KW - Gastric cancer

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=85016425915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016425915&partnerID=8YFLogxK

U2 - 10.3892/or.2017.5442

DO - 10.3892/or.2017.5442

M3 - Article

C2 - 28260059

AN - SCOPUS:85016425915

VL - 37

SP - 1953

EP - 1960

JO - Oncology Reports

JF - Oncology Reports

SN - 1021-335X

IS - 4

ER -